What does grade 3 indicate in the Nottingham histologic grading system for invasive breast carcinoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Grade 3 in the Nottingham Histologic Grading System

Grade 3 in the Nottingham scale indicates poorly differentiated, aggressive breast carcinoma with a score of 8-9 points, signifying high nuclear pleomorphism, minimal glandular/tubular formation, and high mitotic activity—this translates to worse prognosis and typically requires more aggressive systemic therapy. 1

How the Nottingham Grading System Works

The Nottingham method evaluates three specific tumor characteristics, each scored 1-3 points:

  • Glandular/tubular differentiation: Degree of tubule formation
  • Nuclear pleomorphism: Severity of nuclear atypia
  • Mitotic count: Number of mitoses per high-power field

The total score determines the grade:

  • Grade 1: 3-5 points (well differentiated)
  • Grade 2: 6-7 points (moderately differentiated)
  • Grade 3: 8-9 points (poorly differentiated) 1

Clinical Significance of Grade 3

Grade 3 tumors demonstrate the most aggressive biological behavior with significantly worse outcomes compared to lower grades. The prognostic impact is substantial and independent of other factors 2:

  • Survival worsens progressively with increasing grade across all patient subgroups
  • Grade 3 is an independent predictor of both breast cancer-specific survival and disease-free survival
  • This holds true regardless of tumor size (pT1a through pT2) or lymph node status (pN0, pN1, pN2) 2

Molecular and Biological Features

Grade 3 breast cancers exhibit distinct aggressive molecular profiles 3:

  • Overexpression of cell cycle regulatory genes: BIRC5, CDC6, FOXM1, TOP2A, MYBL2, and UBE2C 4
  • Enhanced immunogenicity with increased immune cell infiltration (M1 macrophages, follicular helper T cells, activated NK cells)
  • Elevated T-cell exhaustion markers despite increased cytolytic activity 3
  • Higher MKI67 expression indicating increased proliferation 3
  • More commonly associated with ER-negative status, HER2-positive, and basal subtypes 3

Treatment Implications

Grade 3 designation mandates consideration of systemic chemotherapy, even in otherwise favorable scenarios 5:

  • For lymph node-positive, Grade 3 tumors: Prolonged chemotherapy provides significantly greater survival benefit compared to perioperative chemotherapy alone (p=0.016 for overall survival, p=0.013 for disease-free survival) 6
  • For lymph node-negative patients: Grade 3 status increases hazard ratio to 1.437 (p=0.045), though benefit from chemotherapy is less clear in this subgroup 6
  • Grade 3 tumors should be treated as high-risk regardless of special histologic subtypes—for example, medullary carcinoma with high nuclear grade should be treated as other infiltrating ductal carcinomas based on size, grade, and nodal status 5

Critical Caveats

Reproducibility is good but not perfect when using the standardized Nottingham system, with strong correlation (kappa=82%) between observers 6. However:

  • The system requires proper training and adherence to standardized criteria
  • Grade 3 identifies a larger proportion of high-risk tumors compared to older Bloom-Richardson systems 6
  • For favorable histology tumors (pure tubular, pure mucinous, pure cribriform): If these are Grade 3, high-grade, or HER2-positive, they lose their favorable designation and should be treated as ductal/no special type 7

The Nottingham grade has been incorporated into the 8th edition AJCC staging system as a surrogate marker for tumor biology, reflecting its established prognostic value 3.

References

Research

Classification and grading of invasive breast carcinoma.

Verhandlungen der Deutschen Gesellschaft fur Pathologie, 2005

Research

Prognostic significance of Nottingham histologic grade in invasive breast carcinoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008

Guideline

breast cancer. clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

Guideline

breast cancer, version 3.2024, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2024

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.